Publications:

Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response.

Nature Communications

Pagadala, Meghana M; Sears, Timothy J TJ; Wu, Victoria H VH; Pérez-Guijarro, Eva E; Kim, Hyo H; Castro, Andrea A; Talwar, James V JV; Gonzalez-Colin, Cristian C; Cao, Steven S; Schmiedel, Benjamin J BJ; Goudarzi, Shervin S; Kirani, Divya D; Au, Jessica J; Zhang, Tongwu T; Landi, Teresa T; Salem, Rany M RM; Morris, Gerald P GP; Harismendy, Olivier O; Patel, Sandip Pravin SP; Alexandrov, Ludmil B LB; Mesirov, Jill P JP; Zanetti, Maurizio M; Day, Chi-Ping CP; Fan, Chun Chieh CC; Thompson, Wesley K WK; Merlino, Glenn G; Gutkind, J Silvio JS; Vijayanand, Pandurangan P; Carter, Hannah H

Publication Date: 2023-05-12

Variant appearance in text: TAGLN: A95A

PubMed Link: 37173324

Variant Present in the following documents:

• 41467_2023_38271_MOESM4_ESM.xlsx, sheet 3

View BVdb publication page

Pseudo-obstruction-inducing ACTG2R257C alters actin organization and function.

Jci Insight

Hashmi, Sohaib Khalid SK; Barka, Vasia V; Yang, Changsong C; Schneider, Sabine S; Svitkina, Tatyana M TM; Heuckeroth, Robert O RO

Publication Date: 2020-08-20

Variant appearance in text: TAGLN: A95A

PubMed Link: 32814715

Variant Present in the following documents:

• Main text

View BVdb publication page